115 - Impact of Pneumonia Panel Implementation with Stewardship Support on Antibiotic De-escalation in the ICU

Thursday, October 12, 2023

12:40 PM – 12:45 PM US ET

Location: Poster Hall B+C - Arena 2

Rapid Fire Presenter(s)

Trevor C. Van Schooneveld, MD, FSHEA, FACP

Professor, Division of Infectious Diseases
University of Nebraska Medical Center
Omaha, NE, United States

Co-Author(s)

Scott J. Bergman, PharmD

Pharmacy Coordinator
Nebraska Medicine
Omaha, Nebraska, United States
EL

Elizabeth Lyden, MS

Associate Director, Center for Collaboration on Research, Design and Analysis
University of Nebraska Medical Center
Omaha, Nebraska, United States
PF

Paul Fey, PhD

University of Nebraska Medical Center
Omaha, Nebraska, United States
Molly M. Miller, PharmD, BCIDP

Clinical Pharmacist Practitioner
Nebraska Medicine
Omaha, Nebraska, United States
MA

Mary Kate Anderson, MS

UNMC
Omaha, Nebraska, United States
AK

Akshay Kashyap, BS

University of Nebraska Medical Center
Omaha, Nebraska, United States
SM

Sara Mantz, B.S.

UNMC
Omaha, Nebraska, United States
RV

Rachel Vetter, BS

UNMC
Omaha, Nebraska, United States
PW

Paul Wurtz, n/a

University of Nebraska Medical Center
Omaha, Nebraska, United States
Erica J. Stohs, MD, MPH (she/her/hers)

Assistant Professor
University of Nebraska Medical Center
Omaha, NE, United States

Disclosure(s):

Trevor C. Van Schooneveld, MD: AN2 Therapeutics: Grant/Research Support (); Biomeriuex: Advisor/Consultant (), Grant/Research Support (); Insmed: Grant/Research Support (); Thermo-Fischer: Honoraria ()

Erica J. Stohs, MD, MPH: bioMerieux: Grant/Research Support (Ongoing); Merck: Grant/Research Support (Ongoing)